Affinity Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$632K Buy
4,984
+107
+2% +$12.5K 0.08% 98
2026
Q1
$587K Buy
4,877
+147
+3% +$17K 0.08% 94
2025
Q4
$498K Buy
4,730
+824
+21% +$77.3K 0.07% 103
2025
Q3
$350K Sell
3,906
-10
-0.3% -$824 0.05% 117
2025
Q2
$310K Sell
3,916
-11
-0.3% -$874 0.05% 124
2025
Q1
$311K Sell
3,927
-50
-1% -$4.67K 0.06% 118
2024
Q4
$402K Sell
3,977
-102
-3% -$10.5K 0.08% 107
2024
Q3
$463K Buy
4,079
+249
+7% +$29.6K 0.09% 100
2024
Q2
$474K Hold
3,830
0.1% 96
2024
Q1
$505K Sell
3,830
-165
-4% -$20.3K 0.11% 92
2023
Q4
$436K Sell
3,995
-35
-0.9% -$3.63K 0.11% 96
2023
Q3
$415K Sell
4,030
-88
-2% -$9.48K 0.11% 88
2023
Q2
$475K Buy
4,118
+43
+1% +$4.88K 0.13% 79
2023
Q1
$434K Hold
4,075
0.13% 79
2022
Q4
$452K Sell
4,075
-38
-0.9% -$3.88K 0.16% 67
2022
Q3
$354K Buy
4,113
+1
+0% +$89 0.12% 73
2022
Q2
$375K Sell
4,112
-36
-0.9% -$3.19K 0.13% 73
2022
Q1
$340K Sell
4,148
-108
-3% -$8.52K 0.11% 84
2021
Q4
$326K Buy
4,256
+21
+0.5% +$1.67K 0.1% 90
2021
Q3
$318K Sell
4,235
-2,078
-33% -$158K 0.11% 87
2021
Q2
$491K Sell
6,313
-303
-5% -$22.5K 0.17% 72
2021
Q1
$487K Sell
6,616
-106
-2% -$7.82K 0.18% 69
2020
Q4
$525K Hold
6,722
0.21% 58
2020
Q3
$532K Buy
6,722
+37
+0.6% +$2.9K 0.3% 52
2020
Q2
$493K Sell
6,685
-231
-3% -$17.4K 0.32% 51
2020
Q1
$551K Sell
6,916
-1,222
-15% -$96K 0.4% 47
2019
Q4
$706K Buy
+8,138
New +$668K 0.46% 38

Other funds holding MRK

Affinity Capital Advisors's MRK Position: Q2 2026 in Review

Affinity Capital Advisors increased its Merck (MRK) stake by 2.2% in Q2 2026, buying an estimated $12.5K and bringing the position to 4,984 shares worth $632K. The position accounts for 0.08% of the portfolio, ranked #98.

Affinity Capital Advisors first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. The position peaked at $706K in Q4 2019. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Affinity Capital Advisors held 4,984 shares of Merck worth $632K as of Q2 2026.
  • Affinity Capital Advisors bought 107 Merck shares in Q2 2026, an estimated $12.5K.
  • Merck made up 0.08% of Affinity Capital Advisors's portfolio in Q2 2026, its #98 holding.
  • Affinity Capital Advisors first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • Affinity Capital Advisors's Merck position peaked at $706K in Q4 2019.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Affinity Capital Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.